Leuprolide Mesylate
Prostate cancer needs hormones called androgens to grow. Testosterone is the primary male androgen. Leuprolide mesylate causes the testicles to stop making testosterone. This may stop the growth of cancer cells or shrink the tumor. Leuprolide mesylate is a type of androgen deprivation therapy called a gonadotropin-releasing hormone agonist.
FDA label information for this drug is available at DailyMed.
Use in Cancer
Leuprolide mesylate is approved to treat advanced prostate cancer in adults.
More About Leuprolide Mesylate
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Leuprolide Mesylate - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Research Results and Related Resources
Targeted Therapy to Treat Cancer
Hormone Therapy for Prostate Cancer
Clinical Trials Accepting Patients
Find Clinical Trials for Leuprolide Mesylate - Check for trials from NCI's list of cancer clinical trials now accepting patients.